{
    "nctId": "NCT03454529",
    "briefTitle": "The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer",
    "officialTitle": "The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women With Early Stage Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 24,
    "primaryOutcomeMeasure": "Change in Ki-67 Expression Assessed in Tumor Tissue by Immunohistochemistry",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Provision of informed consent prior to any study specific procedures\n* Histologic confirmation of invasive breast cancer with any measures of ER, PR and HER2neu\n* Clinical stage I or II breast cancer for which there will be at least a 2 week period of time between diagnosis and definitive surgery\n* Performance status (Eastern Cooperative Oncology Group \\[ECOG\\] 0-1)\n* Not currently pregnant during the study; participants will be informed that the use of contraceptive pills is contraindicated because it may interfere with the study drug and it may be harmful to the woman who has been diagnosed with breast cancer\n\nExclusion Criteria:\n\n* Plans for administration of neoadjuvant chemotherapy or hormonal therapy\n* Insufficient tissue on diagnostic core breast biopsy for analysis\n* Previous or concurrent malignancy (with the exception of non-melanomatous skin cancer)\n* Severe gastrointestinal disorder\n* Current use of statins or fibrates for any time during the 3 months prior to the study\n* Proven hypersensitivity to statins\n* White blood cell (WBC) \\< 3,500/mm\\^3\n* Platelet (Plt) \\< 120,000/mm\\^3\n* Hemoglobin (HgB) \\< 10 g/dL\n* Aspartate aminotransferase (AST) \\> 45 U/L\n* Alanine aminotransferase (ALT) \\> 45 U/L\n* Creatinine \\> 1.5 mg/dL\n* Bilirubin \\> 1.15 mg/dL\n* Creatine kinase measurement (CPK) \\> or = 250 mg/dL\n* Central nervous system (CNS) diseases and major psychiatric diseases or inability to comply to the protocol procedures\n* Active infections\n* Cardiac failure, class I-IV\n* Current anticoagulant or antiplatelet aggregation therapy\n* Mitral and/or tricuspid valvopathy or valvular prosthesis; angina; severe arterial hypertension; chronic and/or paroxysmal atrial fibrillation; previous myocardial infarction\n* Current lactation",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}